Note: Ingredients listed on restricted chemical lists
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
N/A
EC/CAS
14464-46-1
Name of the chemical
Cristobalit (s. u. TRGS 906)
Concentration
N/A
EC/CAS
238-878-4
Name of the chemical
Quarz-A-Staub (s. u. TRGS 906)
Concentration
N/A
EC/CAS
238-455-4
Name of the chemical
Cristobalit (s. u. TRGS 906)
Concentration
N/A
General Information
Revision date
2017-12-18
Product name
Bellavest DR (REF 54861, 54862)
1.2.1 Relevant identified uses
Manufacturing of dental prosthesis in a dental laboratory
Emergency telephone
For medical advice (in German and English
Icons in SDS
Company Information
company name
BEGO Bremer Goldschlägerei
e-mail address of the competent person responsible for the Safety Data Sheet
msds@bego.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H372i
Section 2
2.1 Classification of the substance or mixture
Classification in accordance with Regulation (EC) No 1272/2008 (CLP) STOT RE 1; H372i
Classifications
This product is assessed and classified using the methods and criteria below referred to in Article 9 of Regulation (EC) n° 1272/2008:
Physical hazards
determined through assessment data based on the methods or standards referred to in part 2 of Annex I to CLP
Health hazards
determined through toxicological and ecotoxicological assessment data based on the methods or standards referred to in Part 3, 4 and 5 of Annex I to CLP.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 (CLP Regulation)
Hazard pictograms
GHS08
Signal word
Danger Hazardous component(s) to be indicated on label: Quartz (SiO2) cristobalite
Hazard statements
H372i Causes damage to organs through prolonged or repeated exposure if inhaled.
Precautionary statements
P260 Do not breathe dust. P314 Get medical advice/attention if you feel unwell. P501 Dispose of contents/container to a facility in accordance with local and national regulations.
2.3 Other hazards
Depending on the handling and use (eg. grinding, drying) formation of airborne respirable crystalline silica is possible. Prolonged and / or massive inhalation of respirable crystalline silica can cause silicosis disease (silicosis). Main symptoms of silicosis are cough and breathing problems / shortness of breath. In case of irregular exposure to respirable crystalline silica appropriate safety and surveillance measures should exist. The handling of the product should be carried out with special care in order to avoid dust formation. PBT assessment No data available. vPvB assessment No data available.
